16 May 2015 in Adelaide, Australia
Another chemotherapy reaction? Hyperpigmentation due to alkylating agents revisited
Anti-itching and barrier restoring effects of alipid-replenishing balm on atopic dermatitis models
Antibiotic therapy for Staphylococcus aureus colonisedvascular catheter tips and the occurrence ofbacteraemia – implications for hospital policy
Approach to hypopigmentation or depigmentationin children
Apremilast, an oral phosphodiesterase 4 inhibitor, inpatients with moderate to severe psoriasis: 52-weekresults of the ESTEEM 2 Trial
Apremilast, an oral phosphodiesterase 4 inhibitor, inpatients with nail, scalp, and palmoplantar psoriasis:52-week ESTEEM 2 study results
Assessing skin diseases in patients with pigmented skin(a grey area)
Assessment of attitudes towards sun-protectivebehaviour in Australia: a cross-sectional studyA. Lee
Assessment of delays to diagnosis of nodularmelanoma compared to superficial spreadingmelanoma
Assessment of pharmacists’ knowledge about use oftopical corticosteroids in atopic dermatitis: pre- andpost-continuing professional development education
Air travel induced cutaneous leucocytoclastic vasculitis
Allergic contact dermatitis to alcohol swabs masquerading as a tape allergy
How to become a dermatologist in the Netherlands!
Acute non–sexually acquired genital ulceration in a post-partum woman
Severe atopic dermatitis with ectodermal dysplasia: A case report
Topical crushed prednisolone use in recalcitrant peristomal pyoderma gangrenosum
2021 Dermcoll, 53RD ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
2019 Dermcoll, 52ND ANNUAL SCIENTIFIC MEETING